Investing for tomorrow

Discover our funds

  • 155bn€

    Assets under management as at 31 December 2024

  • 25

    years of ESG experience

You are browsing from Switzerland! Would you like to change your location?
Equities, Healthcare, Servaas Michielssens, Linden Thomson

Biotech : 25 years of innovation in the service of healthcare

Over the past twenty-five years, the medical biotechnology sector has profoundly transformed the therapeutic landscape. From the fight against cancer to the development of Covid-19 vaccines in record time, advances in biopharma have changed the outcome for millions of patients worldwide.
CSR Report 2023
Weekly Views
What's next

Latest Insights

  • Ken Van Weyenberg, Equities

    Reshoring: A Catalyst for Smart Manufacturing

    Global manufacturers are navigating a highly challenging environment marked by tariffs, trade conflicts and new alliances, supply chain disruptions, and rising geopolitical tensions.
  • US elections, Asset Allocation, Macro, Florence Pisani, Emile Gagna, Lauren Goodwin

    Trump’s Economic Policy

    The election of Donald Trump, coupled with the Republican Party's control of both houses of Congress, has resulted in a new political landscape in the United States. What key decisions must the new administration make? What impact will these decisions have on the macroeconomic environment, financial markets and investors?
  • Fixed Income, Sylvain De Bus, Philippe Dehoux

    Bonds are Back…So Which Ones?

    European yields have returned to more historical norms following the years in the low-yield wilderness, while the German fiscal situation is reaching an inflection point.
  • Charudatta Shende, Fixed Income

    Credit: Go with the Flows

    April unfolded as a month of intense turbulence in financial markets, driven by a barrage of political manoeuvrings, economic uncertainty, and shifting monetary policies. Markets were rattled by elevated tariffs, escalating rhetoric, and retaliatory measures that prompted investors to reassess growth prospects, price in heightened recession risks, and retreat from riskier assets.
  • Private Debt

    Private Debt and its Role in Your Portfolio

    Direct loans to mid-sized companies have the potential to generate stable returns for investors. This increasingly-relevant investment is now accessible to individuals as well as institutions. 
Insights
“At Candriam, we embrace Conviction and Responsibility in everything we do.”
Vincent Hamelink, CEO

Expertise

Thematic

Find it fast

Get information faster with a single click

Get insights straight to your inbox